Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

273.69
Delayed Data
As of 3:59pm ET
 -1.30 / -0.47%
Today’s Change
242.07
Today|||52-Week Range
420.99
-10.66%
Year-to-Date

Today’s Trading

Previous close274.99
Today’s open274.74
Day’s range268.88 - 274.99
Volume1,359,264
Average volume (3 months)1,838,570
Market cap$60.2B
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+10.72%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-3.87%
P/E ratio16.8
Price/Sales7.60
Price/Book6.41

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc+0.19+0.45%
BAXBaxter International...+0.49+1.11%
JUNOJuno Therapeutics In...+0.20+0.48%
CTLTCatalent Inc-0.12-0.41%
Data as of 4:02pm ET, 05/02/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.58
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs